Provided by Tiger Fintech (Singapore) Pte. Ltd.

Chemours

11.12
+0.46004.32%
Post-market: 11.120.00000.00%18:48 EDT
Volume:4.10M
Turnover:45.84M
Market Cap:1.66B
PE:61.65
High:11.36
Open:10.94
Low:10.77
Close:10.66
Loading ...

Bain’s done with the Insignia M&A battle, so where’s CC Capital?

The Australian Financial Review
·
06 Jun

Damian Gumpel, President of Titanium Technologies, Reports Acquisition of Chemours Company Common Shares

Reuters
·
05 Jun

Insignia Gets New Bull on Valuation Gap to CC Capital Offer -- Market Talk

Dow Jones
·
04 Jun

Cocrystal Pharma’s CC-42344 Shows Strong Antiviral Potency

TIPRANKS
·
29 May

Chemours Is Maintained at Equal-Weight by Barclays

Dow Jones
·
28 May

Barclays Sticks to Their Hold Rating for Chemours Company (CC)

TIPRANKS
·
28 May

BUZZ-Chemical companies gain on US-EU trade deal optimism

Reuters
·
28 May

CFO Makes Bold Move with Major Chemours Stock Purchase

TIPRANKS
·
22 May

Shane Hostetter, Chief Financial Officer, Reports Acquisition of Common Shares in The Chemours Company

Reuters
·
22 May

Chemours, DataVolt to Develop Advanced Liquid Cooling Technologies for Data Centers

MT Newswires Live
·
19 May

Chemours announces strategic agreement with DataVolt

TIPRANKS
·
19 May

Chemours and Datavolt Announce Agreement to Accelerate Adoption of Liquid Cooling Solutions & Support Broader Innovation for Future-Ready AI Data Centers

THOMSON REUTERS
·
19 May

Leading broker says this ASX 200 tech stock is a top buy

MotleyFool
·
16 May

Goldman Sachs Adjusts Chemours Price Target to $14 From $21, Maintains Neutral Rating

MT Newswires Live
·
14 May

Chemours Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
14 May

Analysts Offer Insights on Materials Companies: Endeavour Silver (EXK) and Chemours Company (CC)

TIPRANKS
·
14 May

Insignia Financial Confirms Takeover Talks With CC Capital; Bain Capital Withdraws Bid

MT Newswires Live
·
14 May

Press Release: Natura &Co Latam rebounds from last quarter and achieves 15% profitability in Q1-25

Dow Jones
·
13 May

3M Settles PFAS-Related Claims with New Jersey for $285 Million, Resolving Legacy Chambers Works Litigation

Reuters
·
13 May

Morgan Stanley Adjusts Chemours Price Target to $15 From $22, Maintains Equal Weight Rating

MT Newswires Live
·
12 May